Skip to main content
. Author manuscript; available in PMC: 2019 Jan 30.
Published in final edited form as: Int J Pharm. 2017 Nov 28;536(1):397–404. doi: 10.1016/j.ijpharm.2017.11.036

Table 2.

Stability of LMN-NKA (1.5 mg and 5 mg) in ODT under long-term storage conditions (25 °C/60% relative humidity) and under accelerated conditions (40 °C/75% relative humidity) for up to 90 days. Data shown as mean ± SD (N=3).

Condition
(°C/%RH)
Claimed
Strength
(mg)
Day14 Day 28 Day 90
Actual
Strength (mg)
%
Label Claim
Actual
Strength (mg)
%
Label Claim
Actual
Strength (mg)
%
Label Claim
25/60 1.5 1.59 ± 0.03 106.4 ± 2.0 1.56 ± 0.01 103.8 ± 0.8 1.46 ± 0.02 97.2 ± 1.6
25/60 5 5.03 ± 0.06 100.7 ±1.3 5.23 ± 0.05 104.7 ± 1.0 5.11 ± 0.02 102.2 ± 0.3
45/75 1.5 1.59 ± 0.08 105.7 ± 5.5 1.59 ± 0.08 104.6 ± 0.7 1.46 ± 0.02 97.4 ± 1.1
45/75 5 4.96 ± 0.06 99.1 ± 1.2 4.82 ± 0.23 96.5 ± 4.5 4.92 ± 0.11 98.4 ± 2.3